Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Excellos logo — A unique full-service CDMO, setting new standards in Cell &...

Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

Founded 2021 United States San Diego, United States 38 employees Corporate Round Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name Excellos
Founded Year 2021
Location United States San Diego, United States
Employees 38
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with Excellos. To contact Excellos, visit excellos.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Excellos compare?

A PDF of Excellos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Excellos soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Excellos

Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new industry standard. The company excels in collecting critical human cells and tissues and providing manufacturing and development services for the cell and gene therapy industry, with a specific focus on therapies in preclinical through phase II/III, and scalable operations for commercial use. Excellos' last investment was a $5.00M Venture Round investment on 16 August 2023. The company has been able to secure this investment without disclosing the specific investors. With its commitment to leveraging donor populations for life science research and advancing cellular therapies, Excellos is poised to contribute significantly to the healthcare industry.

Business keywords: Cell and Gene Therapy, CDMO, cGMP Manufacturing, TIL Therapies, CAR-T Therapy, Immunotherapy, Clinical Manufacturing, Life Science Research, Human Cell and Tissue Collection, Process Development, Global Scale Operations, Donor Pool Access, San Diego Blood Bank, Institutional Expertise

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round Undisclosed 1
Vitalant
17 Jan 2024
Venture Round $5.00M -
16 Aug 2023
Funding Round $15.00M 1
Telegraph Hill Partners
Telegraph Hill Partners
25 Jan 2022

Excellos Alternatives & Competitors

View All Alternatives
Excellos vs
Cognate BioServices, a Charles River Company
Cognate BioServices, a Charles River Company United States

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Series B
81 employees
Biotechnology, Health Care
Compare Excellos vs Cognate BioServices, a Charles River Company
Excellos vs
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. United States

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is...

IPO
925 employees
Biotechnology, Health Care
Compare Excellos vs Iovance Biotherapeutics, Inc.
Excellos vs
Astraveus
Astraveus France

We build high tech equipment supporting end-to-end development and manufacture of cell and gene ther...

Debt Financing
69 employees
Biotechnology, Life Sciences
Also compare with: Excellos vs eXmoor pharma eXmoor pharma View all alternatives

FAQ About Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy
Excellos was founded in 2021.
Excellos is headquartered in San Diego, United States.
Excellos operates in Biotechnology, Health Care and Life Sciences. Its work centres on Cell and Gene Therapy, CDMO, cGMP Manufacturing and TIL Therapies.
Excellos has approximately 38 employees.
Excellos has completed 3 funding rounds, raising a total of $20.00M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Excellos include Cognate BioServices, a Charles River Company, Iovance Biotherapeutics, Inc., Astraveus, xcellbio, eXmoor pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Excellos and Cognate BioServices, a Charles River Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Excellos, https://bouncewatch.com/company/excellos, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes